Crop Biolabs was selected, among 300 Brazilian companies, in the “Land to Launch” program for internationalization in New York City (NYC). The program is in its second edition and is organized by SEBRAE and the National Confederation of Industry (CNI), in partnership with Sosa, a global open innovation company.
The selection
Throughout the program, which aims to accelerate the internationalization of Brazilian companies, all selected companies had access to training on fundamental approaches to the North American market, scaling their solutions, and establishing direct contact with world-renowned accelerators.
The program went through three selection stages: selection of 300 Brazilian companies to participate; detailed assessment of business and product models (selecting 30 companies to proceed to the next selection stage in the program); and evaluation of pitches and individual interviews for the selection of the 7 companies that will go on to a residency in NYC. Crop was selected in 1st place.
NYC Stay
The 7 selected companies will participate in preparation meetings, followed by a residency in New York, funded by the program, to implement and scale their businessess in the North American market.
Crop Biolabs will be represented by our CEO, Aruã Prudenciatti, throughout the residency in NYC.
Since science knows no geographical boundaries, we are excited to explore the ecosystem of NYC and contribute with our services”
Aruã Prudenciatti, CEO of Crop Biolabs
What is Crop
Crop is an integrated R&D laboratory specializing in preclinical efficacy and safety services, using alternative cell culture and molecular biology methodologies for the advanced therapeutics, pharmaceutical, cosmetic ingredients, and sanitizing industries.
